Clinical efficacy evaluation of Huoxiang Zhengqi water in the treatment of children's spleen and stomach diseases by percutaneous (navel) administration -- an observational study

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR2200006436

Enrollment

Unknown

Registered

2022-08-04

Start date

2022-07-27

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spleen and stomach diseases in children

Interventions

control group/experimental group:Huoxiang Zhengqi water navel paste

Eligibility

Sex/Gender

All

Age

0.5 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1)Subjects met diagnostic criteria. 2)Subject age: 6 months-18 years old. 3)No other transdermal administration or systemic therapy was received prior to inclusion in the study.

Exclusion criteria

Exclusion criteria: 1) Those who have a history of allergy to Huoxiangzhengqi water/liquid; 2) Patients with cognitive dysfunction, disturbance of consciousness, mental illness, reading dysfunction or language and communication dysfunction; patients with other serious diseases, such as malignant tumors, liver and kidney insufficiency, cardiovascular and cerebrovascular diseases, etc.; 3) Participants in other clinical trials.

Design outcomes

Primary

Measure	Time frame
TCM syndrome score;	—

Countries

China

Contacts

Public ContactLiu Qian

Jiangxi University of Traditional Chinese Medicine

20211008@jxutcm.edu.cn18907979876

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026